Hepatitis B virus, also known as HBV or Orthohepadnavirus, is a type of virus that belongs to the Hepadnaviridae family of viruses. Hepatitis B is brought on by the virus HBV. The ground squirrel hepatitis virus, the woodchuck hepatitis virus, and the woolly monkey hepatitis B virus are the other three species that make up the Orthohepadnavirus, of which the hepatitis B virus is the type species. The Hepadnaviridae family includes the genus as a member. Based on antigenic epitopes found on its envelope proteins, HBV is classified into four major serotypes (adr, adw, ayr, ayw), and eight genotypes (A-H) based on the genome's overall nucleotide sequence variation.The genotypes are used to track the evolution and spread of the virus because they have a distinct geographic distribution. The severity of the disease, the progression and propensity for complications, the response to treatment, and perhaps vaccination, are all impacted by genotype differences.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
V52007 | HBV-IN-31 | 2413192-95-5 | HBV (hepatitis B virus)-IN-31 is a potent inhibitor of covalently closed circular DNA (cccDNA). | |
V52006 | HBV-IN-32 | 2413193-04-9 | HBV (hepatitis B virus)-IN-31 is a potent inhibitor of covalently closed circular DNA (cccDNA). | |
V79034 | HBV-IN-33 | HBV (hepatitis B virus)-IN-33 (C-49) is an inhibitor (blocker/antagonist) of HBV (hepatitis B virus) and significantly inhibits HBV (hepatitis B virus) replication in HepAD38, HepG2-HBV (hepatitis B virus)1.3 and HepG2-NTCP cells. | ||
V54179 | HBV-IN-34 | 2716906-45-3 | HBV (hepatitis B virus)-IN-34 (compound 17i) is a potent inhibitor of HBsAg production. | |
V79441 | HBV-IN-35 | HBV (hepatitis B virus)-IN-35 (Compound 88) is an HBV (hepatitis B virus) inhibitor. | ||
V79710 | HBV-IN-36 | HBV (hepatitis B virus)-IN-36 (compound 42) is a potent HBV (hepatitis B virus) inhibitor (IC50=2 μM) with antiviral effect. | ||
V54204 | HBV-IN-37 | 380483-01-2 | HBV (hepatitis B virus)-IN-37 is an HBV (hepatitis B virus) inhibitor (antagonist) with EC50 of 10 μM. | |
V54210 | HBV-IN-38 | 1834483-86-1 | HBV (hepatitis B virus)-IN-38 (Example 193) is an HBV (hepatitis B virus) DNA inhibitor (EC50≤100nM). | |
V54200 | HBV-IN-39-d3 | 2173356-23-3 | HBV (hepatitis B virus)-IN-39-d3 (Example 14) is a deuterated form of HBV (hepatitis B virus)-IN-39 (Example 13). | |
V78340 | HBV-IN-40 | HBV (hepatitis B virus)-IN-40 (Compound 11826096) is an HBV (hepatitis B virus) inhibitor (IC50= 0.7 μM). | ||
V54183 | HBV-IN-41 | 1967002-25-0 | HBV (hepatitis B virus)-IN-41 (compound 45) is a potent orally bioactive HBV (hepatitis B virus) inhibitor (antagonist) with EC50 of 0.027μM. | |
V85418 | HBV-IN-43 | 2305897-05-4 | ||
V54197 | HBV-IN-6 | 2724224-47-7 | HBV (hepatitis B virus)-IN-6 is a potent HBV (hepatitis B virus) inhibitor (antagonist) with EC50 of 44 nM. | |
V54185 | HBV-IN-7 | 2724224-49-9 | HBV (hepatitis B virus)-IN-6 is a potent HBV (hepatitis B virus) inhibitor (antagonist) with EC50 of 5 nM. | |
V54175 | HBV-IN-8 | 2724224-57-9 | HBV (hepatitis B virus)-IN-6 is a potent HBV (hepatitis B virus) inhibitor (antagonist) with EC50 of 287.9 nM. | |
V54176 | HBV-IN-9 | 2170998-69-1 | HBV (hepatitis B virus)-IN-9 (example 20) is a potent HBsAg (HBV (hepatitis B virus) surface antigen) inhibitor (IC50=10 nM) and HBV (hepatitis B virus) DNA replication inhibitor (IC50=0.15 nM). | |
V54188 | Hepatitis B Virus Receptor Binding Fragment (hepatitis B peptide 4980) | 114495-85-1 | Hepatitis B Virus Receptor Binding Fragment (hepatitis B peptide 4980) is a synthetic peptide analog that specifically binds to Hep G2 cells. | |
V51949 | Inarigivir ammonium (ORI-9020 ammonium; SB-9000 ammonium) | 2172788-92-8 | Inarigivir (ORI-9020) ammonium is a dinucleotide antiviral compound that significantly reduces HBV (hepatitis B virus) DNA in transgenic mice expressing hepatitis B virus. | |
V29343 | Isoscopoletin | 776-86-3 | Isoscopoletin is a novel and potent bioactive compound. | |
V4501 | JNJ-632 | 1572510-42-9 | JNJ-632 is a novel and potent hepatitis B virus (HBV) capsid assembly modulator (CAM). |